RxSight, Inc.
US ˙ NasdaqGM ˙ US78349D1072

SecurityRXST / RxSight, Inc.
InstitutionUBS Group AG
Latest Disclosed Ownership239,456 shares
Latest Disclosed Value $ 1,475,049
UBS Group AG reports 61.66% decrease in ownership of RXST / RxSight, Inc.

On May 5, 2026 - UBS Group AG filed a 13F-HR form disclosing ownership of 239,456 shares of RxSight, Inc. (US:RXST) valued at $1,475,049 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 624,600 shares of RxSight, Inc.. This represents a change in shares of -61.66% during the quarter. The current value of the position is $1,146,994 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F RXSIGHT COM 78349D107 239,456 -385,144 -61.66 1,475 -77.34 0.0000
2026-01-29 2025-12-31 13F RXSIGHT COM 78349D107 624,600 -110,570 -15.04 6,508 -1.53 0.0002
2025-11-13 2025-09-30 13F RXSIGHT COM 78349D107 735,170 475,395 183.00 6,609 95.71 0.0010
2025-08-14 2025-06-30 13F RXSIGHT COM 78349D107 259,775 178,350 219.04 3,377 64.33 0.0006
2025-05-13 2025-03-31 13F RXSIGHT COM 78349D107 81,425 -133,621 -62.14 2,056 -72.20 0.0004
2025-02-14 2024-12-31 13F RXSIGHT COM 78349D107 215,046 190,885 790.05 7,393 519.18 0.0014
2024-11-14 2024-09-30 13F RXSIGHT COM 78349D107 24,161 5,796 31.56 1,194 8.05 0.0003
2024-08-14 2024-06-30 13F RXSIGHT COM 78349D107 18,365 -13,599 -42.54 1,105 -32.95 0.0003
2024-05-13 2024-03-31 13F RXSIGHT COM 78349D107 31,964 -2,693 -7.77 1,649 17.97 0.0004
2024-02-09 2023-12-31 13F RXSIGHT COM 78349D107 34,657 16,434 90.18 1,397 175.00 0.0004
2023-11-09 2023-09-30 13F RXSIGHT COM 78349D107 18,223 -729 -3.85 508 -6.79 0.0002
2023-08-11 2023-06-30 13F RXSIGHT COM 78349D107 18,952 11,301 147.71 546 329.13 0.0002
2023-05-12 2023-03-31 13F RXSIGHT COM 78349D107 7,651 2,263 42.00 128 86.76 0.0000
2023-02-08 2022-12-31 13F RXSIGHT COM 78349D107 5,388 4,339 413.63 68 423.08 0.0000
2022-11-10 2022-09-30 13F RXSIGHT COM 78349D107 1,049 1,049 13 0.0000
2022-08-10 2022-06-30 13F RXSIGHT COM 78349D107 0 -3,888 -100.00 0 -100.00
2022-05-16 2022-03-31 13F RXSIGHT COM 78349D107 3,888 282 7.82 48 20.00 0.0000
2022-02-14 2021-12-31 13F RXSIGHT COM 78349D107 3,606 3,606 40 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.